Global Health
RSSArticles
-
Conference replays offer educational opportunity
-
Bioterrorism Watch: CDC gets plenty of advice for action
-
Bioterrorism Watch: Was anthrax mailer a bioweapons researcher?
-
Updates: Fungal Prophylaxis in Preemies; nongonococcal urethritis; hepatitis E
-
Updates: Smallpox vaccine trial; D4T phenotypic resistance; VAQTA withdrawal
-
Clinical Briefs in Primary Care Supplement
-
CDC, NIH lab lapses with deadly agents lead to calls to halt research
A recent series of stunning lapses and oversights in federal research labs working with deadly pathogens and potential bioterror agents has heightened calls for a moratorium on such research until biosafety and security can be assured. -
The bottom of the iceberg: Is there a hidden hepatitis epidemic beneath all of the outpatient outbreaks?
Once thought of as shocking outliers, the continuing hepatitis outbreaks in ambulatory care settings and clinics increasingly suggest that for every cluster detected, many more infections acquired in health care are being missed due to inadequate surveillance systems and lack of public health resources to investigate individual cases. -
CDC mulling hep B shots in nursing homes
In light of continuing outbreaks of hepatitis in ambulatory and long-term care, the Centers for Disease Control and Prevention is considering recommending hepatitis B virus vaccination for diabetic residents of nursing homes. -
Toxic staph strain may be emerging
The recently reported rapid deaths of two patients infected with a new highly toxic staph strain suggests the deadly pathogen is emerging in the community and certainly will pose a threat to hospitals, a researcher tells Hospital Infection Control & Prevention.